QT Imaging Holdings, Inc.(QTI)

Medical - Devices · Novato, CA

$2.67+0.06 (+2.30%)

Delayed quote: Oct 6, 2026, 2:22 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T18:32:44.415Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:32:44.415Z.

Quote observation: 2026-10-06T18:22:33.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 2.67
Unrounded diluted TTM EPS · period ending 2026-06-30: -1.17

FMP input reference: 73a05a26affbff61ca245286eab2f65fbc602d03c7bc752639a64992bef0efba

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

QTI PE Ratio Metrics

PE RATIO

N/A

QTI Competitors' PE Ratio

QTI

QT Imaging Holdings, Inc.

Current

Market Cap

$36.76M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELTX

Elicio Therapeutics, Inc.

vs QTI

Market Cap

$36.23M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs QTI

Market Cap

$35.69M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEPH

Nephros, Inc.

vs QTI

Market Cap

$38.32M

PE Ratio

22.24

TTM Avg

36.35

3Y Avg

61.12

5Y Avg

61.12

EDSA

Edesa Biotech, Inc.

vs QTI

Market Cap

$36.75M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCGO

DocGo Inc.

vs QTI

Market Cap

$35.56M

PE Ratio

N/A

TTM Avg

14.70

3Y Avg

37.22

5Y Avg

37.36

BCTX

BriaCell Therapeutics Corp.

vs QTI

Market Cap

$35.06M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IXHL

Incannex Healthcare Limited

vs QTI

Market Cap

$37.68M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELUT

Elutia Inc

vs QTI

Market Cap

$34.04M

PE Ratio

0.82

TTM Avg

1.13

3Y Avg

1.13

5Y Avg

1.13

GRCE

Grace Therapeutics, Inc.

vs QTI

Market Cap

$34.42M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
QT Imaging Holdings, Inc. (QTI)	$36.76M	N/A	N/A	N/A	N/A
Elicio Therapeutics, Inc. (ELTX)vs ›	$36.23M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$35.69M	N/A	N/A	N/A	N/A
Nephros, Inc. (NEPH)vs ›	$38.32M	22.24	36.35	61.12	61.12
Edesa Biotech, Inc. (EDSA)vs ›	$36.75M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$35.56M	N/A	14.70	37.22	37.36
BriaCell Therapeutics Corp. (BCTX)vs ›	$35.06M	N/A	N/A	N/A	N/A
Incannex Healthcare Limited (IXHL)vs ›	$37.68M	N/A	N/A	N/A	N/A
Elutia Inc (ELUT)vs ›	$34.04M	0.82	1.13	1.13	1.13
Grace Therapeutics, Inc. (GRCE)vs ›	$34.42M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$2.67

Forward EPS (Est.)

$-1.11

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

QTI PE Ratio Metrics

QTI Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics